SR One News

BY CATEGORY: ALL / NOTABLE / CLINICAL IMPACT / NEW INVESTMENTS / FINANCING AND PARTNERSHIPS / PEOPLE

BY YEAR: 2023 / 2022 / 2021 / 2020

Second Genome granted U.S. patent for proteins for the treatment or prevention of epithelial barrier function disorders

Frances Benson 12/20/21 Frances Benson 12/20/21

Second Genome granted U.S. patent for proteins for the treatment or prevention of epithelial barrier function disorders

Read More

Palleon Pharmaceuticals appoints Denis Patrick to its Board of Directors

Frances Benson 12/16/21 Frances Benson 12/16/21

Palleon Pharmaceuticals appoints Denis Patrick to its Board of Directors

Read More

Nkarta receives U.S. FDA orphan drug designation for NKX101 for treatment of patients with AML

Frances Benson 12/16/21 Frances Benson 12/16/21

Nkarta receives U.S. FDA orphan drug designation for NKX101 for treatment of patients with AML

Read More

Arcellx presents continued robust long-term responses from its CART-ddBCMA Ph1 expansion trial

Frances Benson 12/13/21 Frances Benson 12/13/21

Arcellx presents continued robust long-term responses from its CART-ddBCMA Ph1 expansion trial

Read More

Tranquis Therapeutics announces initiation of Ph1 study of TQS-168

Frances Benson 12/8/21 Frances Benson 12/8/21

Tranquis Therapeutics announces initiation of Ph1 study of TQS-168

Read More

Nomic Bio raises $17M in Series A

Frances Benson 12/8/21 Frances Benson 12/8/21

Nomic Bio raises $17M in Series A

Read More

Odyssey Therapeutics raises $218M in Series A

Frances Benson 12/7/21 Frances Benson 12/7/21

Odyssey Therapeutics raises $218M in Series A

Read More

Pulmocide receives $3.5M investment from the Cystic Fibrosis Foundation

Frances Benson 12/6/21 Frances Benson 12/6/21

Pulmocide receives $3.5M investment from the Cystic Fibrosis Foundation

Read More

HotSpot Therapeutics raises $100M in Series C

Frances Benson 11/29/21 Frances Benson 11/29/21

HotSpot Therapeutics raises $100M in Series C

Read More

CRISPR Therapeutics announces FDA Regenerative Medicine Advanced Therapy (RMAT) designation granted to CTX110™

Frances Benson 11/22/21 Frances Benson 11/22/21

CRISPR Therapeutics announces FDA Regenerative Medicine Advanced Therapy (RMAT) designation granted to CTX110™

Read More

Palleon presents data on sialoglycan degradation platform that enhances anti-tumor T-cell immunity

Frances Benson 11/9/21 Frances Benson 11/9/21

Palleon presents data on sialoglycan degradation platform that enhances anti-tumor T-cell immunity

Read More

Tranquis Therapeutics presents positive preclinical data on TQS-168 for the treatment of ALS

Frances Benson 11/3/21 Frances Benson 11/3/21

Tranquis Therapeutics presents positive preclinical data on TQS-168 for the treatment of ALS

Read More

BioTheryX receives IND clearance from FDA to proceed with Ph1 Study of BTX-1188

Frances Benson 11/2/21 Frances Benson 11/2/21

BioTheryX receives IND clearance from FDA to proceed with Ph1 Study of BTX-1188

Read More

Palleon Pharmaceuticals appoints David Johnson to its Board of Directors

Frances Benson 11/2/21 Frances Benson 11/2/21

Palleon Pharmaceuticals appoints David Johnson to its Board of Directors

Read More

BioTheryX appoints Philippe Drouet as CEO

Frances Benson 10/28/21 Frances Benson 10/28/21

BioTheryX appoints Philippe Drouet as CEO

Read More

Bicycle Therapeutics raises $201.3M

Frances Benson 10/18/21 Frances Benson 10/18/21

Bicycle Therapeutics raises $201.3M

Read More

CRISPR Therapeutics reports positive results from its Ph1 CARBON Trial of CTX110™

Frances Benson 10/12/21 Frances Benson 10/12/21

CRISPR Therapeutics reports positive results from its Ph1 CARBON Trial of CTX110™

Read More

Bicycle Therapeutics announces preliminary results from Ph1 oncology trials

Frances Benson 10/7/21 Frances Benson 10/7/21

Bicycle Therapeutics announces preliminary results from Ph1 oncology trials

Read More

Turning Point Therapeutics granted breakthrough therapy designation for Repotrectinib treatment

Frances Benson 10/4/21 Frances Benson 10/4/21

Turning Point Therapeutics granted breakthrough therapy designation for Repotrectinib treatment

Read More

MiroBio appoints Dr. Carolin Barth as CEO

Frances Benson 9/21/21 Frances Benson 9/21/21

MiroBio appoints Dr. Carolin Barth as CEO

Read More